Selected research
Industry Research
Transdermal Skin Patches Industry Research Report 2026
Market perspective
The global Transdermal Skin Patches market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Transdermal Skin Patches is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Transdermal Skin Patches is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Transdermal Skin Patches is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Transdermal Skin Patches include Hisamitsu Pharmaceutical, Luye Pharma Group, Mundipharma International, Purdue Pharma, Mylan N.V., Novartis AG, Johnson & Johnson and Teva Pharmaceutical Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Transdermal Skin Patches market in terms of revenue (US$ million) and, where applicable, sales volume (M Pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Pcs) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Transdermal Skin Patches Market by Company
Hisamitsu Pharmaceutical
Luye Pharma Group
Mundipharma International
Purdue Pharma
Mylan N.V.
Novartis AG
Johnson & Johnson
Teva Pharmaceutical Industries
Transdermal Skin Patches Segment by Type
Drug in Adhesive
Reservoir
Vapor
Matrix
Others
Transdermal Skin Patches Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Transdermal Skin Patches Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Skin Patches market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Skin Patches and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Skin Patches.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Transdermal Skin Patches manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Transdermal Skin Patches by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Transdermal Skin Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Drug in Adhesive
- Reservoir
- Vapor
- Matrix
- Others
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Hisamitsu Pharmaceutical
- Luye Pharma Group
- Mundipharma International
- Purdue Pharma
- Mylan N.V.
- Novartis AG
- Johnson & Johnson
- Teva Pharmaceutical Industries
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Transdermal Skin Patches Market Size (2021-2032)
- 2.2.2 Global Transdermal Skin Patches Sales (2021-2032)
- 2.2.3 Global Transdermal Skin Patches Market Average Price (2021-2032)
- 2.3 Transdermal Skin Patches by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Drug in Adhesive
- 2.3.3 Reservoir
- 2.3.4 Vapor
- 2.3.5 Matrix
- 2.3.6 Others
- 2.4 Transdermal Skin Patches by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacies
- 2.4.3 Online Pharmacies
- 2.4.4 Retail Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Transdermal Skin Patches Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Transdermal Skin Patches Sales (M Pcs) of Manufacturers (2021-2026)
- 3.3 Global Transdermal Skin Patches Revenue of Manufacturers (2021-2026)
- 3.4 Global Transdermal Skin Patches Average Price by Manufacturers (2021-2026)
- 3.5 Global Transdermal Skin Patches Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Transdermal Skin Patches, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Transdermal Skin Patches, Product Type & Application
- 3.8 Global Manufacturers of Transdermal Skin Patches, Established Date
- 3.9 Global Transdermal Skin Patches Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Hisamitsu Pharmaceutical
- 4.1.1 Hisamitsu Pharmaceutical Company Information
- 4.1.2 Hisamitsu Pharmaceutical Business Overview
- 4.1.3 Hisamitsu Pharmaceutical Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patches Product Portfolio
- 4.1.5 Hisamitsu Pharmaceutical Recent Developments
- 4.2 Luye Pharma Group
- 4.2.1 Luye Pharma Group Company Information
- 4.2.2 Luye Pharma Group Business Overview
- 4.2.3 Luye Pharma Group Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Luye Pharma Group Transdermal Skin Patches Product Portfolio
- 4.2.5 Luye Pharma Group Recent Developments
- 4.3 Mundipharma International
- 4.3.1 Mundipharma International Company Information
- 4.3.2 Mundipharma International Business Overview
- 4.3.3 Mundipharma International Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mundipharma International Transdermal Skin Patches Product Portfolio
- 4.3.5 Mundipharma International Recent Developments
- 4.4 Purdue Pharma
- 4.4.1 Purdue Pharma Company Information
- 4.4.2 Purdue Pharma Business Overview
- 4.4.3 Purdue Pharma Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Purdue Pharma Transdermal Skin Patches Product Portfolio
- 4.4.5 Purdue Pharma Recent Developments
- 4.5 Mylan N.V.
- 4.5.1 Mylan N.V. Company Information
- 4.5.2 Mylan N.V. Business Overview
- 4.5.3 Mylan N.V. Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Mylan N.V. Transdermal Skin Patches Product Portfolio
- 4.5.5 Mylan N.V. Recent Developments
- 4.6 Novartis AG
- 4.6.1 Novartis AG Company Information
- 4.6.2 Novartis AG Business Overview
- 4.6.3 Novartis AG Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Novartis AG Transdermal Skin Patches Product Portfolio
- 4.6.5 Novartis AG Recent Developments
- 4.7 Johnson & Johnson
- 4.7.1 Johnson & Johnson Company Information
- 4.7.2 Johnson & Johnson Business Overview
- 4.7.3 Johnson & Johnson Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Johnson & Johnson Transdermal Skin Patches Product Portfolio
- 4.7.5 Johnson & Johnson Recent Developments
- 4.8 Teva Pharmaceutical Industries
- 4.8.1 Teva Pharmaceutical Industries Company Information
- 4.8.2 Teva Pharmaceutical Industries Business Overview
- 4.8.3 Teva Pharmaceutical Industries Transdermal Skin Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Teva Pharmaceutical Industries Transdermal Skin Patches Product Portfolio
- 4.8.5 Teva Pharmaceutical Industries Recent Developments
5 Global Transdermal Skin Patches Market Scenario by Region
- 5.1 Global Transdermal Skin Patches Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Transdermal Skin Patches Sales by Region: 2021-2032
- 5.2.1 Global Transdermal Skin Patches Sales by Region: 2021-2026
- 5.2.2 Global Transdermal Skin Patches Sales by Region: 2027-2032
- 5.3 Global Transdermal Skin Patches Revenue by Region: 2021-2032
- 5.3.1 Global Transdermal Skin Patches Revenue by Region: 2021-2026
- 5.3.2 Global Transdermal Skin Patches Revenue by Region: 2027-2032
- 5.4 North America Transdermal Skin Patches Market Facts & Figures by Country
- 5.4.1 North America Transdermal Skin Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Transdermal Skin Patches Sales by Country (2021-2032)
- 5.4.3 North America Transdermal Skin Patches Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Transdermal Skin Patches Market Facts & Figures by Country
- 5.5.1 Europe Transdermal Skin Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Transdermal Skin Patches Sales by Country (2021-2032)
- 5.5.3 Europe Transdermal Skin Patches Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Transdermal Skin Patches Market Facts & Figures by Country
- 5.6.1 Asia Pacific Transdermal Skin Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Transdermal Skin Patches Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Transdermal Skin Patches Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Transdermal Skin Patches Market Facts & Figures by Country
- 5.7.1 South America Transdermal Skin Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Transdermal Skin Patches Sales by Country (2021-2032)
- 5.7.3 South America Transdermal Skin Patches Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Transdermal Skin Patches Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Transdermal Skin Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Transdermal Skin Patches Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Transdermal Skin Patches Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Transdermal Skin Patches Sales by Type (2021-2032)
- 6.1.1 Global Transdermal Skin Patches Sales by Type (2021-2032) & (M Pcs)
- 6.1.2 Global Transdermal Skin Patches Sales Market Share by Type (2021-2032)
- 6.2 Global Transdermal Skin Patches Revenue by Type (2021-2032)
- 6.2.1 Global Transdermal Skin Patches Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Transdermal Skin Patches Revenue Market Share by Type (2021-2032)
- 6.3 Global Transdermal Skin Patches Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Transdermal Skin Patches Sales by Application (2021-2032)
- 7.1.1 Global Transdermal Skin Patches Sales by Application (2021-2032) & (M Pcs)
- 7.1.2 Global Transdermal Skin Patches Sales Market Share by Application (2021-2032)
- 7.2 Global Transdermal Skin Patches Revenue by Application (2021-2032)
- 7.2.1 Global Transdermal Skin Patches Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Transdermal Skin Patches Revenue Market Share by Application (2021-2032)
- 7.3 Global Transdermal Skin Patches Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Transdermal Skin Patches Value Chain Analysis
- 8.1.1 Transdermal Skin Patches Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Transdermal Skin Patches Production Mode & Process
- 8.2 Transdermal Skin Patches Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Transdermal Skin Patches Distributors
- 8.2.3 Transdermal Skin Patches Customers
9 Global Transdermal Skin Patches Analyzing Market Dynamics
- 9.1 Transdermal Skin Patches Industry Trends
- 9.2 Transdermal Skin Patches Industry Drivers
- 9.3 Transdermal Skin Patches Industry Opportunities and Challenges
- 9.4 Transdermal Skin Patches Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst